ALS Untangled does not endorse caffeine as an ALS treatment
Original source
Caffeine (opens in a new tab)ALS Untangled reviewed caffeine as a possible treatment for amyotrophic lateral sclerosis (ALS). It found contradictory results in preclinical models and no clear relationship between caffeine intake and disease progression in two cohort studies. The review does not endorse caffeine as an ALS treatment.
Why this matters
People with ALS should not interpret the available evidence as showing that caffeine slows disease progression. The review says caffeine is inexpensive and reasonably safe at doses below 400 mg daily, but this does not establish a treatment benefit. [S1]
Limitations and context
This is an independent expert review, not a new clinical trial. The evidence it assessed includes contradictory preclinical findings and two cohort studies, which found no clear relationship between caffeine intake and ALS progression. The review does not establish whether caffeine benefits people with ALS or changes treatment decisions. [S1]